Literature DB >> 29288528

Overexpression of miR-22 attenuates oxidative stress injury in diabetic cardiomyopathy via Sirt 1.

Qinghui Tang1, Qiang Len2, Zheng Liu2, WeiDong Wang3.   

Abstract

BACKGROUND/AIMS: Oxidative stress injury is believed to be important in diabetic cardiomyopathy. Recent evidence indicates that miR-22 plays an important role in various cardiovascular diseases, but the protective role of miR-22 in diabetic cardiomyopathy remains undetermined.
METHODS: Diabetes was induced in male C57BL/6 mice by intraperitoneal injection with streptozotocin combined with a high-fat diet, and miR-22 was overexpressed following transfection with adeno-associated virus. Cardiac function was assessed by echocardiography and a cardiac catheter system. In vitro study, H9c2 cells were treated with normal or high glucose (HG), and cell viability or apoptosis was detected using the Cell Counting Kit-8 (CCK-8) assay and flow cytometry, respectively. Reactive oxygen species, malondialdehyde, and superoxide dismutase were also detected in diabetic mice and H9c2 cells. The expression level of miR-22 was detected by real-time PCR. The protein expression of Sirt 1, oxidative stress injury-related proteins (GRP78, CHOP, ATF 3), and apoptosis-related proteins Bax/Bcl-2, cl-casp-9/casp-9, and cl-casp-3/casp-3 were determined by Western blotting analysis.
RESULTS: HG-induced oxidative stress injury and apoptosis were observed in H9c2 cells, which were ameliorated by miR-22. Cardiac dysfunction and severely altered heart structure were also observed in diabetic mice and were dramatically reversed by overexpression of miR-22. The expression of Sirt 1 decreased significantly in diabetic mice and HG-treated H9c2 cells. Overexpression of miR-22 restored the level of Sirt 1. Bioinformatics analysis predicted that Sirt 1 was a potential target gene of miR-22. Luciferase reporter assay verified that miR-22 promoted Sirt 1 expression by direct binding to the Sirt 1 3'untranslated repeats. Upregulation of Sirt 1 could improve cell viability and attenuate oxidative stress injury and apoptosis in the HG-treated H9c2 cells, similar to the effect of miR-22. However, the protective effects of miR-22 against HG-induced oxidative stress injury and apoptosis were abrogated by knockdown of Sirt 1.
CONCLUSIONS: Overexpression of miR-22 can attenuate oxidative stress injury in diabetic cardiomyopathy by upregulation of Sirt 1 in vivo and in vitro.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  Sirt 1; diabetic cardiomyopathy; high glucose; miR-22; oxidative stress

Mesh:

Substances:

Year:  2018        PMID: 29288528     DOI: 10.1111/1755-5922.12318

Source DB:  PubMed          Journal:  Cardiovasc Ther        ISSN: 1755-5914            Impact factor:   3.023


  20 in total

1.  NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance.

Authors:  Francesco Marampon; Silvia Codenotti; Francesca Megiorni; Andrea Del Fattore; Simona Camero; Giovanni Luca Gravina; Claudio Festuccia; Daniela Musio; Francesca De Felice; Valerio Nardone; Anna Natalizia Santoro; Carlo Dominici; Alessandro Fanzani; Luigi Pirtoli; Antonella Fioravanti; Vincenzo Tombolini; Sara Cheleschi; Paolo Tini
Journal:  J Cancer Res Clin Oncol       Date:  2019-01-30       Impact factor: 4.553

Review 2.  Non-coding RNA involvement in the pathogenesis of diabetic cardiomyopathy.

Authors:  Wei Zhang; Weiting Xu; Yu Feng; Xiang Zhou
Journal:  J Cell Mol Med       Date:  2019-06-26       Impact factor: 5.310

Review 3.  Current Status and Potential Therapeutic Strategies for Using Non-coding RNA to Treat Diabetic Cardiomyopathy.

Authors:  Amit K Rai; Brooke Lee; Ramesh Gomez; Deepu Rajendran; Mahmood Khan; Venkata Naga Srikanth Garikipati
Journal:  Front Physiol       Date:  2021-01-22       Impact factor: 4.566

Review 4.  Epigenetic Regulation Associated With Sirtuin 1 in Complications of Diabetes Mellitus.

Authors:  Jie Wang A; Shudong Wang; Jie Wang B; Mengjie Xiao; Yuanfang Guo; Yufeng Tang; Jingjing Zhang; Junlian Gu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-18       Impact factor: 5.555

Review 5.  MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics.

Authors:  Daniel Jakubik; Alex Fitas; Ceren Eyileten; Joanna Jarosz-Popek; Anna Nowak; Pamela Czajka; Zofia Wicik; Harald Sourij; Jolanta M Siller-Matula; Salvatore De Rosa; Marek Postula
Journal:  Cardiovasc Diabetol       Date:  2021-02-27       Impact factor: 9.951

Review 6.  Targeting microRNAs as a Therapeutic Strategy to Reduce Oxidative Stress in Diabetes.

Authors:  Giuseppina Emanuela Grieco; Noemi Brusco; Giada Licata; Laura Nigi; Caterina Formichi; Francesco Dotta; Guido Sebastiani
Journal:  Int J Mol Sci       Date:  2019-12-17       Impact factor: 5.923

7.  MicroRNA‑494 suppresses hypoxia/reoxygenation‑induced cardiomyocyte apoptosis and autophagy via the PI3K/AKT/mTOR signaling pathway by targeting SIRT1.

Authors:  Shuwei Ning; Zhiying Li; Zhenyu Ji; Dandan Fan; Keke Wang; Qian Wang; Lei Hua; Junyue Zhang; Xiangguang Meng; Yiqiang Yuan
Journal:  Mol Med Rep       Date:  2020-10-26       Impact factor: 2.952

Review 8.  Cellular Protein Quality Control in Diabetic Cardiomyopathy: From Bench to Bedside.

Authors:  Namrita Kaur; Rida Raja; Andrea Ruiz-Velasco; Wei Liu
Journal:  Front Cardiovasc Med       Date:  2020-10-15

9.  Bioinformatic gene analysis for potential therapeutic targets of Huntington's disease in pre-symptomatic and symptomatic stage.

Authors:  Chunchen Xiang; Shengri Cong; Bin Liang; Shuyan Cong
Journal:  J Transl Med       Date:  2020-10-14       Impact factor: 5.531

Review 10.  The Role of microRNAs in Metabolic Syndrome-Related Oxidative Stress.

Authors:  Adam Włodarski; Justyna Strycharz; Adam Wróblewski; Jacek Kasznicki; Józef Drzewoski; Agnieszka Śliwińska
Journal:  Int J Mol Sci       Date:  2020-09-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.